is this you? Claim your profile.
is this you? Claim your profile.
HQ Phone:  (888) 659-6630
Direct Phone: (910) ***-****
+ Get 10 Free Contacts a Month
It's free and takes 30 seconds
2629 W. 32Nd Ave.
TranS1 is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region. TranS1 currently markets the AxiaLIF® family of products for single and two level lumbar fusio... more.
Cutlass Capital LLC
Co-Founder and Managing Member
Member of Audit Committee, Member
Evalve , Inc.
Amos Tuck School of Business at Dartmouth
Amos Truck School of Business at Dartmouth College
Amos Tuck School of Business Administration at Dartmouth
Board of Directors | Trans1
Jonathan Osgood has served as a member of our Board since March 2002. In 2001, Mr. Osgood co-founded, and is a managing member of, Cutlass Capital, L.L.C a venture capital firm that invests exclusively in the healthcare industry. Mr. Osgood has served as a member of the board of directors of several privately-held medical device companies and as a member of the audit committee and compensation committee of several of such companies. Mr. Osgood is a Certified Financial Analyst and received a B.A degree in Economics from Dartmouth College and an M.B.A. degree from the Amos Truck School of Business at Dartmouth College. Mr. Osgood's experience and attributes qualify him to serve on our Board for several reasons. Virtually his entire 38 year business career has been spent in and around the health care industry. From 1984 until 2000, Mr. Osgood led Alex. Brown & sons' and Deutsche Bank's Health Care Research practice, where he advised clients in their health care investing strategy. From 2001 to the present, as a managing member of Cutlass Capital, L.L.C., Mr. Osgood has been investing in privately owned health care companies, primarily in the medical device space. As a result of this experience, Mr. Osgood has broad and deep experience in working with and analyzing health care companies, and has developed a large network of health care company executives, entrepreneurs, physicians, investment bankers and venture capitalists.
Osgood | Jon Osgood
Cutlass Capital Jonathan W. Osgood, C.F.A. Co-Founder and Managing Member, Boston Office. Prior to founding Cutlass Capital, Jon was a research analyst at Deutsche Banc Alex. Brown and its predecessors from 1983 to 2000. He was Global Head of Health Care Research from 1984 until 2000, and headed one of the largest health care research departments on Wall Street with over 40 professionals worldwide. His industry analytical responsibilities included every sector of health care, with special emphasis on medical technology and health care information systems. Jon was elected several times to the Institutional Investor All-America Research Team and was named a Wall Street Journal All-Star for his stock picking ability. Jon is a Director of CardioKinetix, Inc., GI Dynamics, Inc., Hemosphere, Inc., TranS1, Inc., and Xoft, Inc. He was previously an Observer on the Board of Evalve, Inc. In addition, he serves on the Board of Overseers of Beth Israel Deaconess Medical Center in Boston. Jon has a BA (Magna Cum Laude and Phi Beta Kappa) from Dartmouth College and an MBA (Amos Tuck Scholar) from the Amos Tuck School of Business Administration at Dartmouth.
0001414339 Osgood Jonathan W. C/O CUTLASS CAPITAL 322 DUNBARTON DRIVE ST. SIMONS ISLAND GA 31522 1 0 0 0
0001414339 Osgood Jonathan W. C/O CUTLASS CAPITAL 229 MARLBOROUGH ST BOSTON MA 02116 1 0 0 0
About : Board Of Directors : Minimally invasive surgical procedures for the spine